CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance

CITED2 (Cbp/p300‐interacting transactivator, with Glu/Asp‐rich carboxy‐terminal domain, 2) is a member of the CITED family and is involved in various cellular functions during development and differentiation. Mounting evidence suggests the importance of CITED in the progression of human malignancies...

Descripción completa

Detalles Bibliográficos
Autores principales: Minemura, Hiroyuki, Takagi, Kiyoshi, Sato, Ai, Takahashi, Hikaru, Miki, Yasuhiro, Shibahara, Yukiko, Watanabe, Mika, Ishida, Takanori, Sasano, Hironobu, Suzuki, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198946/
https://www.ncbi.nlm.nih.gov/pubmed/27627783
http://dx.doi.org/10.1111/cas.13081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198946/
https://www.ncbi.nlm.nih.gov/pubmed/27627783
http://dx.doi.org/10.1111/cas.13081

Ejemplares similares